Literature DB >> 28678930

Ruthenium Complex Improves the Endothelial Function in Aortic Rings From Hypertensive Rats.

Izabela Pereira Vatanabe1, Carla Nascimento Dos Santos Rodrigues1, Tereza Cristina Buzinari1, Thiago Francisco de Moraes1, Roberto Santana da Silva2, Gerson Jhonatan Rodrigues1.   

Abstract

BACKGROUND: : The endothelium is a monolayer of cells that extends on the vascular inner surface, responsible for the modulation of vascular tone. By means of the release of nitric oxide (NO), the endothelium has an important protective function against cardiovascular diseases.
OBJECTIVE: : Verify if cis- [Ru(bpy)2(NO2)(NO)](PF6)2 (BPY) improves endothelial function and the sensibility of conductance (aorta) and resistance (coronary) to vascular relaxation induced by BPY.
METHODS: : Normotensive (2K) and hypertensive (2K-1C) Wistar rats were used. For vascular reactivity study, thoracic aortas were isolated, rings with intact endothelium were incubated with: BPY(0.01 to10 µM) and concentration effect curves to acetylcholine were performed. In addition, cumulative concentration curves were performed to BPY (1.0 nM to 0.1 µM) in aortic and coronary rings, with intact and denuded endothelium.
RESULTS: : In aorta from 2K-1C animals, the treatment with BPY 0.1µM increased the potency of acetylcholine-induced relaxation and it was able to revert the endothelial dysfunction. The presence of the endothelium did not modify the effect of BPY in inducing the relaxation in aortas from 2K and 2K-1C rats. In coronary, the endothelium potentiated the vasodilator effect of BPY in vessels from 2K and 2K-1C rats.
CONCLUSION: : Our results suggest that 0.1 µM of BPY is able to normalize the relaxation endothelium dependent in hypertensive rats, and the compound BPY induces relaxation in aortic from normotensive and hypertensive rats with the same potency. The endothelium potentiate the relaxation effect induced by BPY in coronary from normotensive and hypertensive rats, with lower effect on coronary from hypertensive rats. FUNDAMENTO:: O endotélio é uma monocamada de células que se estende sobre a superfície interna vascular, responsável pela modulação do tônus vascular. Por meio da liberação de óxido nítrico (NO), o endotélio tem uma função protetora importante contra doenças cardiovasculares. OBJETIVO:: Verificar se o cis- [Ru (BPY)2 (NO2) (NO)] (PF6) 2 (BPY) melhora a função endotelial e a sensibilidade da condutância (aorta) e da resistência (coronária) ao relaxamento vascular induzido por BPY. MÉTODOS:: Foram utilizados ratos Wistar normotensos (2K) e hipertensos (2K-1C). Para o estudo de reatividade vascular, as aortas torácicas foram isoladas, os anéis com endotélio intacto foram incubados com: BPY (0,01 a 10 µM) e se realizaram curvas de efeito de concentração para acetilcolina. Adicionalmente, foram feitas curvas de concentração cumulativas para BPY (1,0 nM a 0,1 µM) nos anéis aórticos e coronários, com endotélio intacto e nu. RESULTADOS:: Na aorta de animais 2K-1C, o tratamento com BPY 0,1 µM aumentou a potência do relaxamento induzido pela acetilcolina e foi capaz de reverter a disfunção endotelial. A presença do endotélio não modificou o efeito da BPY na indução do relaxamento em aortas de ratos 2K e 2K-1C. Na coronária, o endotélio potencializou o efeito vasodilatador do BPY em vasos de ratos 2K e 2K-1C. CONCLUSÃO:: Nossos resultados sugerem que 0,1 µM de BPY é capaz de normalizar o relaxamento dependente do endotélio em ratos hipertensos, e o composto BPY induz relaxamento na aorta de ratos normotensos e hipertensos com a mesma potência. O endotélio potencializa o efeito de relaxamento induzido pela BPY em coronárias de ratos normotensos e hipertensos, com menor efeito em coronárias de ratos hipertensos.

Entities:  

Year:  2017        PMID: 28678930      PMCID: PMC5576116          DOI: 10.5935/abc.20170090

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  24 in total

1.  Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.

Authors:  T Münzel; H Li; H Mollnau; U Hink; E Matheis; M Hartmann; M Oelze; M Skatchkov; A Warnholtz; L Duncker; T Meinertz; U Förstermann
Journal:  Circ Res       Date:  2000-01-07       Impact factor: 17.367

2.  Hypotensive and vasorelaxing effects of the new NO-donor [Ru(terpy)(bdq)NO(+)](3+) in spontaneously hypertensive rats.

Authors:  Felipe C Munhoz; Simone R Potje; Amanda C Pereira; Marcella G Daruge; Roberto S da Silva; Lusiane M Bendhack; Cristina Antoniali
Journal:  Nitric Oxide       Date:  2012-01-08       Impact factor: 4.427

3.  Decreased vasodilation induced by a new nitric oxide donor in two kidney, one clip hypertensive rats is due to impaired k channel activation.

Authors:  Daniella Bonaventura; Fabiana S Oliveira; Roberto S da Silva; Lusiane M Bendhack
Journal:  Clin Exp Pharmacol Physiol       Date:  2005 May-Jun       Impact factor: 2.557

Review 4.  New nitric oxide donors based on ruthenium complexes.

Authors:  C N Lunardi; R S da Silva; L M Bendhack
Journal:  Braz J Med Biol Res       Date:  2009-01       Impact factor: 2.590

5.  Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats.

Authors:  S Guan; J Fox; K D Mitchell; L G Navar
Journal:  Hypertension       Date:  1992-12       Impact factor: 10.190

6.  Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells.

Authors:  M Feelisch; M Kelm
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

7.  A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation.

Authors:  Daniella Bonaventura; Fabiana de S Oliveira; Vanessa Togniolo; Antonio C Tedesco; Roberto S da Silva; Lusiane M Bendhack
Journal:  Nitric Oxide       Date:  2004-03       Impact factor: 4.427

8.  Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats.

Authors:  G J Rodrigues; C N Lunardi; R G Lima; C X Santos; F R M Laurindo; R S da Silva; L M Bendhack
Journal:  Nitric Oxide       Date:  2007-12-25       Impact factor: 4.427

9.  Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donor in renal hypertensive rats.

Authors:  Cristiane Masetto de Gaitani; Miriam C C de Melo; Claure N Lunardi; Fabiana de S Oliveira; Roberto S da Silva; Lusiane M Bendhack
Journal:  Nitric Oxide       Date:  2008-12-13       Impact factor: 4.427

10.  Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities.

Authors:  Akiko Fukatsu; Toshio Hayashi; Asaka Miyazaki-Akita; Hisako Matsui-Hirai; Yukie Furutate; Asako Ishitsuka; Yuichi Hattori; Akihisa Iguchi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.